Health-related quality of life (HRQoL) in patients (pts) treated with pembrolizumab (pembro) vs chemotherapy as first-line treatment in microsatellite instability-high (MSI-H) and/or deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Phase III KEYNOTE-177 study
No Thumbnail Available
Identifiers
Date
2020-09-01
Authors
Andre, T.
Amonkar, M.
Norquist, J.
Shiu, K-K.
Kim, T. W.
Jensen, B. V.
Jensen, L. H.
Punt, C. J.
Smith, D.
Garcia-Carbonero, R.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
